Gold nanoparticles do not induce myotube cytotoxicity but increase the susceptibility to cell death

Toxicology in Vitro

Volumn 29, Issue 5, 2015, Pages 819-827

  Leite, Paulo Emílio Corrêa ^a   Pereira, Mariana Rodrigues ^c   Santos, Carlos Antonio do Nascimento ^a   Campos, Andrea Porto Carreiro ^b   Esteves, Ticiana Mota ^a   Granjeiro, José Mauro ^a,c  

^a Divisão de Biologia Celular e Bioengenharia Diretoria de Metrologia Aplicada as Ciências da Vida DIMAV   (Brazil)

^b INSTITUTO NACIONAL DE METROLOGIA   (Brazil)

^c FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Bioengineering; Gold nanoparticle; Inflammation; Nanotoxicity; PEG; Skeletal muscle

Indexed keywords

ADENOSINE TRIPHOSPHATE; CASPASE 3; CASPASE 7; GAMMA INTERFERON; GOLD NANOPARTICLE; MACROGOL; MITOGEN ACTIVATED PROTEIN KINASE; STAUROSPORINE; TRANSFORMING GROWTH FACTOR BETA1; CASP7 PROTEIN, MOUSE; GOLD; MACROGOL DERIVATIVE; METAL NANOPARTICLE; PROTEIN KINASE B; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG CYTOTOXICITY; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; MYOTUBE; NONHUMAN; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; CHEMISTRY; DRUG EFFECTS; METABOLISM; SKELETAL MUSCLE; TUMOR CELL LINE;

ADENOSINE TRIPHOSPHATE; ANIMALS; CASPASE 3; CASPASE 7; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; GOLD; INTERFERON-GAMMA; MEMBRANE POTENTIAL, MITOCHONDRIAL; METAL NANOPARTICLES; MICE; MUSCLE FIBERS, SKELETAL; POLYETHYLENE GLYCOLS; PROTO-ONCOGENE PROTEINS C-AKT; TRANSFORMING GROWTH FACTOR BETA;

EID: 84926305703     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2015.02.010     Document Type: Article

References (48)

1. Abdelhalim M.A. Gold nanoparticles administration induces disarray of heart muscle, hemorrhagic, chronic inflammatory cells infiltrated by small lymphocytes, cytoplasmic vacuolization and congested and dilated blood vessels. Lipids Health Dis. 2011, 10:233.
2. Abdelhalim M.A., Jarrar B.M. Renal tissue alterations were size-dependent with smaller ones induced more effects and related with time exposure of gold nanoparticles. Lipids Health Dis. 2011, 10:163.
3. Acharya S., Hill R.A. High efficacy gold-KDEL peptide-siRNA nanoconstruct-mediated transfection in C2C12 myoblasts and myotubes. Nanomedicine 2014, 10:329-337.
4. Arvizo R.R., Saha S., Wang E., Robertson J.D., Bhattacharya R., Mukherjee P. Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle. Proc. Natl. Acad. Sci. USA 2013, 110:6700-6705.
5. Berridge M.V., Herst P.M., Tan A.S. Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol. Annu. Rev. 2005, 11:127-152.
6. Berridge M.V., Tan A.S. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch. Biochem. Biophys. 1993, 303:474-482.
7. Cho W.S., Cho M., Jeong J., Choi M., Cho H.Y., Han B.S., Kim S.H., Kim H.O., Lim Y.T., Chung B.H. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol. Appl. Pharmacol. 2009, 236:16-24.
8. Chuang S.M., Lee Y.H., Liang R.Y., Roam G.D., Zeng Z.M., Tu H.F., Wang S.K., Chueh P.J. Extensive evaluations of the cytotoxic effects of gold nanoparticles. Biochim. Biophys. Acta 2013, 1830:4960-4973.
9. Chueh P.J., Liang R.Y., Lee Y.H., Zeng Z.M., Chuang S.M. Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines. J. Hazard. Mater. 2014, 264:303-312.
10. Comfort K.K., Maurer E.I., Braydich-Stolle L.K., Hussain S.M. Interference of silver, gold, and iron oxide nanoparticles on epidermal growth factor signal transduction in epithelial cells. ACS Nano 2011, 5:10000-10008.
11. Connor E.E., Mwamuka J., Gole A., Murphy C.J., Wyatt M.D. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 2005, 1:325-327.
12. Fanzani A., Zanola A., Rovetta F., Rossi S., Aleo M.F. Cisplatin triggers atrophy of skeletal C2C12 myotubes via impairment of Akt signalling pathway and subsequent increment activity of proteasome and autophagy systems. Toxicol. Appl. Pharmacol. 2011, 250:312-321.
13. Ghosh R., Singh L.C., Shohet J.M., Gunaratne P.H. A gold nanoparticle platform for the delivery of functional microRNAs into cancer cells. Biomaterials 2013, 34:807-816.
14. Guadagnini R., Halamoda Kenzaoui B., Cartwright L., Pojana G., Magdolenova Z., Bilanicova D., Saunders M., Juillerat L., Marcomini A., Huk A., Dusinska M., Fjellsbo L.M., Marano F., Boland S. Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classic in vitro tests. Nanotoxicology 2013.
15. Guo S., Huang Y., Jiang Q., Sun Y., Deng L., Liang Z., Du Q., Xing J., Zhao Y., Wang P.C., Dong A., Liang X.J. Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte. ACS Nano 2010, 4:5505-5511.
16. James B.P., Bunch T.A., Krishnamoorthy S., Perkins L.A., Brower D.L. Nuclear localization of the ERK MAP kinase mediated by Drosophila alphaPS2betaPS integrin and importin-7. Mol. Biol. Cell 2007, 18:4190-4199.
17. Khan J.A., Pillai B., Das T.K., Singh Y., Maiti S. Molecular effects of uptake of gold nanoparticles in HeLa cells. Chembiochem 2007, 8:1237-1240.
18. Khlebtsov N., Dykman L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem. Soc. Rev. 2011, 40:1647-1671.
19. Li J.J., Hartono D., Ong C.N., Bay B.H., Yung L.Y. Autophagy and oxidative stress associated with gold nanoparticles. Biomaterials 2010, 31:5996-6003.
20. Li Y., Foster W., Deasy B.M., Chan Y., Prisk V., Tang Y., Cummins J., Huard J. Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am. J. Pathol. 2004, 164:1007-1019.
21. Liu Z., Li W., Wang F., Sun C., Wang L., Wang J., Sun F. Enhancement of lipopolysaccharide-induced nitric oxide and interleukin-6 production by PEGylated gold nanoparticles in RAW264.7 cells. Nanoscale 2012, 4:7135-7142.
22. Lyman M.G., Randall J.A., Calton C.M., Banfield B.W. Localization of ERK/MAP kinase is regulated by the alphaherpesvirus tegument protein Us2. J. Virol. 2006, 80:7159-7168.
23. Ma J.S., Kim W.J., Kim J.J., Kim T.J., Ye S.K., Song M.D., Kang H., Kim D.W., Moon W.K., Lee K.H. Gold nanoparticles attenuate LPS-induced NO production through the inhibition of NF-kappaB and IFN-beta/STAT1 pathways in RAW264.7 cells. Nitric Oxide 2010, 23:214-219.
24. Maurice J.M., Gan Y., Ma F.X., Chang Y.C., Hibner M., Huang Y. Bupivacaine causes cytotoxicity in mouse C2C12 myoblast cells: involvement of ERK and Akt signaling pathways. Acta Pharmacol. Sin. 2010, 31:493-500.
25. Mieszawska A.J., Mulder W.J., Fayad Z.A., Cormode D.P. Multifunctional gold nanoparticles for diagnosis and therapy of disease. Mol. Pharm. 2013, 10:831-847.
26. Noh S.M., Kim W.K., Kim S.J., Kim J.M., Baek K.H., Oh Y.K. Enhanced cellular delivery and transfection efficiency of plasmid DNA using positively charged biocompatible colloidal gold nanoparticles. Biochim. Biophys. Acta 2007, 1770:747-752.
27. Oh E., Delehanty J.B., Sapsford K.E., Susumu K., Goswami R., Blanco-Canosa J.B., Dawson P.E., Granek J., Shoff M., Zhang Q., Goering P.L., Huston A., Medintz I.L. Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size. ACS Nano 2011, 5:6434-6448.
28. Ong K.J., Maccormack T.J., Clark R.J., Ede J.D., Ortega V.A., Felix L.C., Dang M.K., Ma G., Fenniri H., Veinot J.G., Goss G.G. Widespread nanoparticle-assay interference: implications for nanotoxicity testing. PLoS One 2014, 9:e90650.
29. Pan Y., Leifert A., Ruau D., Neuss S., Bornemann J., Schmid G., Brandau W., Simon U., Jahnen-Dechent W. Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small 2009, 5:2067-2076.
30. Pan Y., Neuss S., Leifert A., Fischler M., Wen F., Simon U., Schmid G., Brandau W., Jahnen-Dechent W. Size-dependent cytotoxicity of gold nanoparticles. Small 2007, 3:1941-1949.
31. Papasani M.R., Wang G., Hill R.A. Gold nanoparticles: the importance of physiological principles to devise strategies for targeted drug delivery. Nanomedicine 2012, 8:804-814.
32. Rauch I., Muller M., Decker T. The regulation of inflammation by interferons and their STATs. JAKSTAT 2013, 2:e23820.
33. Rayavarapu R.G., Petersen W., Hartsuiker L., Chin P., Janssen H., van Leeuwen F.W., Otto C., Manohar S., van Leeuwen T.G. In vitro toxicity studies of polymer-coated gold nanorods. Nanotechnology 2010, 21:145101.
34. Roy A., Ganguly A., Bosedasgupta S., Das B.B., Pal C., Jaisankar P., Majumder H.K. Mitochondria-dependent reactive oxygen species-mediated programmed cell death induced by 3,3'-diindolylmethane through inhibition of F0F1-ATP synthase in unicellular protozoan parasite Leishmania donovani. Mol. Pharmacol. 2008, 74:1292-1307.
35. Schaeublin N.M., Braydich-Stolle L.K., Maurer E.I., Park K., Maccuspie R.I., Afrooz A.R., Vaia R.A., Saleh N.B., Hussain S.M. Does shape matter? Bioeffects of gold nanomaterials in a human skin cell model. Langmuir 2012, 28:3248-3258.
36. Shukla R., Bansal V., Chaudhary M., Basu A., Bhonde R.R., Sastry M. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 2005, 21:10644-10654.
37. Stockert J.C., Blazquez-Castro A., Canete M., Horobin R.W., Villanueva A. MTT assay for cell viability: intracellular localization of the formazan product is in lipid droplets. Acta Histochem. 2012, 114:785-796.
38. Tatsumi T., Shiraishi J., Keira N., Akashi K., Mano A., Yamanaka S., Matoba S., Fushiki S., Fliss H., Nakagawa M. Intracellular ATP is required for mitochondrial apoptotic pathways in isolated hypoxic rat cardiac myocytes. Cardiovasc. Res. 2003, 59:428-440.
39. Verma A., Stellacci F. Effect of surface properties on nanoparticle-cell interactions. Small 2010, 6:12-21.
40. Vetten M.A., Tlotleng N., Tanner Rascher D., Skepu A., Keter F.K., Boodhia K., Koekemoer L.A., Andraos C., Tshikhudo R., Gulumian M. Label-free in vitro toxicity and uptake assessment of citrate stabilised gold nanoparticles in three cell lines. Part Fibre Toxicol. 2013, 10:50.
41. Wang H.H., Lin C.A., Lee C.H., Lin Y.C., Tseng Y.M., Hsieh C.L., Chen C.H., Tsai C.H., Hsieh C.T., Shen J.L., Chan W.H., Chang W.H., Yeh H.I. Fluorescent gold nanoclusters as a biocompatible marker for in vitro and in vivo tracking of endothelial cells. ACS Nano 2011, 5:4337-4344.
42. Wang L., Li Y.F., Zhou L., Liu Y., Meng L., Zhang K., Wu X., Zhang L., Li B., Chen C. Characterization of gold nanorods in vivo by integrated analytical techniques: their uptake, retention, and chemical forms. Anal. Bioanal. Chem. 2010, 396:1105-1114.
43. Wang S., Yu H., Wickliffe J.K. Limitation of the MTT and XTT assays for measuring cell viability due to superoxide formation induced by nano-scale TiO2. Toxicol. In Vitro 2011, 25:2147-2151.
44. Wu J., Wang Y., Liang S., Ma H. Cytoprotective effect of selective small-molecule caspase inhibitors against staurosporine-induced apoptosis. Drug Des. Devel. Ther. 2014, 8:583-600.
45. Yen H.J., Hsu S.H., Tsai C.L. Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes. Small 2009, 5:1553-1561.
46. You J., Zhou J., Zhou M., Liu Y., Robertson J.D., Liang D., van Pelt C., Li C. Pharmacokinetics, clearance, and biosafety of polyethylene glycol-coated hollow gold nanospheres. Part Fibre Toxicol. 2014, 11:26.
47. Zhang Q., Hitchins V.M., Schrand A.M., Hussain S.M., Goering P.L. Uptake of gold nanoparticles in murine macrophage cells without cytotoxicity or production of pro-inflammatory mediators. Nanotoxicology 2011, 5:284-295.
48. Zhao E., Zhao Z., Wang J., Yang C., Chen C., Gao L., Feng Q., Hou W., Gao M., Zhang Q. Surface engineering of gold nanoparticles for in vitro siRNA delivery. Nanoscale 2012, 4:5102-5109.